Considerations for antibiotic prophylaxis in head and neck cancer surgery

Oral Oncology

Volumn 74, Issue , 2017, Pages 181-187

  Veve, Michael P ^a,b   Davis, Susan L ^c,d   Williams, Amy M ^d   McKinnon, John E ^d   Ghanem, Tamer A ^c,d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Antibiotic prophylaxis; Antimicrobial stewardship; Free tissue transfer; Head and neck cancer; Methicillin resistant Staphylococcus aureus; Microvascular reconstruction; Pseudomonas aeruginosa; Surgical site infections

Indexed keywords

ANTIBIOTIC AGENT;

ADVERSE OUTCOME; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER SURGERY; DRUG ACTIVITY; DRUG EXPOSURE; GRAM NEGATIVE BACTERIUM; HEAD AND NECK CANCER; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SURGICAL INFECTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; BACTERIAL INFECTION; COMPLICATION; HEAD AND NECK TUMOR; MICROBIOLOGY; MICROFLORA;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; HEAD AND NECK NEOPLASMS; HUMANS; MICROBIOTA; SURGICAL WOUND INFECTION;

EID: 85029721310     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2017.09.011     Document Type: Article

References (79)

1. Bartella, A.K., Kamal, M., Teichmann, J., et al. Prospective comparison of perioperative antibiotic management protocols in oncological head and neck surgery. J Craniomaxillofac Surg 45:7 (2017), 1078–1082.
2. Wagner, J.L., Kenny, R.M., Vazquez, J.A., Ghanem, T.A., Davis, S.L., Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head Neck 38:10 (2016), 1449–1454.
3. Cannon, R.B., Houlton, J.J., Mendez, E., Futran, N.D., Methods to reduce postoperative surgical site infections after head and neck oncology surgery. Lancet Oncol 18:7 (2017), e405–e413.
4. Penel, N., Fournier, C., Roussel-Delvallez, M., et al. Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study. Support Care Cancer 12:9 (2004), 634–639.
5. Mazurek, M.J., Rysz, M., Jaworowski, J., et al. Contamination of the surgical field in head and neck oncologic surgery. Head Neck 36:10 (2014), 1408–1412.
6. Penel, N., Lefebvre, J.L., Cazin, J.L., et al. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital- perspective analysis. Int J Oral Maxillofac Surg 37:2 (2008), 135–139.
7. Ketcham, A.S., Bloch, J.H., Crawford, D.T., Lieberman, J.E., Smith, R.R., The role of prophylactic antibiotic therapy in control of staphylococcal infections following cancer surgery. Surg Gynecol Obstet 114 (1962), 345–352.
8. Dor, P., Klastersky, J., Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study). Laryngoscope 83:12 (1973), 1992–1998.
9. Saginur, R., Odell, P.F., Poliquin, J.F., Antibiotic prophylaxis in head and neck cancer surgery. J Otolaryngol 17:2 (1988), 78–80.
10. Piccart, M., Dor, P., Klastersky, J., Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis Suppl 39 (1983), 92–96.
11. Velanovich, V., Choice of treatment for stage I floor-of-mouth cancer. Arch Otolaryngol Head Neck Surg 116 (1990), 951–956.
12. Berríos-Torres, S.I., Umscheid, C.A., Bratzler, D.W., et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg, 2017, 10.1001/jamasurg.2017.0904.
13. World Health Organization. Global guidelines for the prevention of surgical site infection; 2016. Available at: < http://who.int/gpsc/global-guidelines-web.pdf?ua=1> [accessed March 2017].
14. Bratzler, D.W., Dellinger, E.P., Olsen, K.M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm 70 (2013), 195–283.
15. Dort, J.C., Farwell, D.G., Findlay, M., et al. Optimal perioperative care in major head and neck cancer surgery with free flap reconstruction: a consensus review and recommendations from the enhanced recovery after surgery society. JAMA Otolaryngol Head Neck Surg 143 (2017), 292–303.
16. Reiffel AJ, Kamdar MR, Kadouch DJ, Rohde CH, Spector JA. Perioperative antibiotics in the setting of microvascular free tissue transfer: current practices. J Reconstr Microsurg. 2010; 26: 401–7.
17. Antibiotic use in the United States. Centers for Disease Control and Prevention; 2017. Available at: < https://www.cdc.gov/getsmart/pdf/stewardship-report.pdf> [accessed July 2017].
18. Carey, T.S., Boden, S.D., A critical guide to case series reports. Spine 28:15 (2003), 1631–1634.
19. Yarlagadda, B.B., Deschler, D.G., Rich, D.L., et al. Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Head Neck 38:Suppl 1 (2016), E392–E398.
20. Karakida, K., Aoki, T., Ota, Y., et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 16:5 (2010), 334–339.
21. Penel, N., Fournier, C., Lefebvre, D., Lefebvre, J.L., Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 41:3 (2005), 294–303.
22. Durand, M.L., Yarlagadda, B.B., Rich, D.L., et al. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope 125:5 (2015), 1084–1089.
23. Yang, C.H., Chew, K.Y., Solomkin, J.S., Lin, P.Y., Chiang, Y.C., Kuo, Y.R., Surgical site infections among high-risk patients in clean-contaminated head and neck reconstructive surgery: concordance with preoperative oral flora. Ann Plast Surg 71:Suppl 1 (2013), S55–S60.
24. Lotfi, C.J., Cavalcanti Rde, C., Costa e Silva, A.M., et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 138:1 (2008), 74–80.
25. Sepher, A., Gutierrez Santos, B., Chou, C., et al. Antibiotics in head and neck surgery in the setting of malnutrition, tracheotomy, and diabetes. Laryngoscope 119 (2009), 549–553.
26. Park, S.Y., Kim, M.S., Eom, J.S., Lee, J.S., Rho, Y.S., Risk factors and etiology of surgical site infection after radical neck dissection in patients with head and neck cancer. Kor J Intern Med 31:1 (2016), 162–169.
27. Robson, A., Sturman, J., Williamson, P., Conboy, P., Penney, S., Wood, H., Pre-treatment clinical assessment in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 130:S2 (2016), S13–S22.
28. Waltz, P.K., Zuckerbraun, B.S., Surgical site infections and associated operative characteristics. Surg Infect (Larchmt) 18:4 (2017), 447–450.
29. van Kasteren, M.E., Manniën, J., Ott, A., Kullberg, B.J., de Boer, A.S., Gyssens, I.C., Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 44:7 (2007), 921–927.
30. American College of Surgeons National Surgical Quality Improvement Program. Data Variables and Definitions; 2016. Available at: < https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_user_guide_2015.ashx> [accessed March 2017].
31. Surgical site infection (SSI) event. National Healthcare Safety Network, Centers for Disease Control and Prevention; 2017. Available at: < https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf> [accessed March 2017].
32. National action plan to prevent health care–associated infections: road map to elimination. US Department of Health and Human Services; 2013. Available at: < https://health.gov/hcq/prevent-hai-action-plan.asp> [accessed March 2017].
33. Centers for Medicare and Medicaid Services (CMS), HHS, Medicare Program, Hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services; Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period. Fed Regist 75:157 (2010), 50041–50681.
34. Liu, S.A., Tung, K.C., Shiao, J.Y., Chiu, Y.T., Preliminary report of associated factors in wound infection after major head and neck neoplasm operations – does the duration of prophylactic antibiotic matter?. J Laryngol Otol 122 (2008), 403–408.
35. Grant, D.W., Mlodinow, A., Ver Halen, J.P., Kim, J.Y., Catastrophic outcomes in free tissue transfer: a six-year review of the NSQIP database. Plast Surg Int, 2014, 2014, 704206.
36. Langerman, A., Ham, S.A., Pisano, J., Pariser, J., Hohmann, S.F., Meltzer, D.O., Laryngectomy complications are associated with perioperative antibiotic choice. Otolaryngol Head Neck Surg 153:1 (2015), 60–68.
37. Clayman, G.L., Raad, I.I., Hankins, P.D., Weber, R.S., Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 15:6 (1993), 526–531.
38. Leung, W.K., Jin, L.J., Yam, W.C., Samaranayake, L.P., Oral colonization of aerobic and facultatively anaerobic gram-negative rods and cocci in irradiated, dentate, xerostomic individuals. Oral Microbiol Immunol 16:1 (2001), 1–9.
39. Johnson, J.T., Yu, V.L., Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck 11:1 (1989), 27–29.
40. Donlan, R.M., Biofilms: microbial life on surfaces. Emerg Infect Dis 8:9 (2002), 881–890.
41. Flemming, H.C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S.A., Kjelleberg, S., Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14:9 (2016), 563–575.
42. Edmiston, C.E. Jr, Krepel, C.J., Seabrook, G.R., Jochimsen, W.G., Anaerobic infections in the surgical patient: microbial etiology and therapy. Clin Infect Dis 35:Suppl 1 (2002), S112–S118.
43. Becker, G.D., Parell, J., Busch, D.F., Finegold, S.M., Acquarelli, M.J., Anaerobic and aerobic bacteriology in head and neck cancer surgery. Arch Otolaryngol 104:10 (1978), 591–594.
44. Robbins, K.T., Byers, R.M., Cole, R., et al. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 98:8 Pt 1 (1988), 803–806.
45. Johnson, J.T., Yu, V.L., Antibiotic use during major head and neck surgery. Ann Surg 207:1 (1988), 108–111.
46. Rodrigo, J.P., Alvarez, J.C., Gómez, J.R., Suárez, C., Fernández, J.A., Martínez, J.A., Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 19:3 (1997), 188–193.
47. Skitarelić, N., Morović, M., Manestar, D., Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Craniomaxillofac Surg 35:1 (2007), 15–20.
48. Weber, R.S., Raad, I., Frankenthaler, R., et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery: the need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 118:11 (1992), 1159–1163.
49. Johnson, J.T., Yu, V.L., Myers, E.N., et al. An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 155:2 (1987), 331–333.
50. Coskun, H., Erisen, L., Basut, O., Factors affecting wound infection rates in head and neck surgery. Otolaryngol Head Neck Surg 123:3 (2000), 328–333.
51. Pool, C., Kass, J., Spivack, J., et al. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg 154:2 (2016), 272–278.
52. Murphy J, Isaiah A, Dyalram D, Lubek JE. Surgical site infections in patients receiving osteomyocutaneous free flaps to the head and neck. Does choice of antibiotic prophylaxis matter? J Oral Maxillofac Surg 2017;S0278–2391(17):30215-X.
53. Mitchell, R.M., Mendez, E., Schmitt, N.C., et al. Antibiotic prophylaxis in patients undergoing head and neck free flap reconstruction. JAMA Otolaryngol Head Neck Surg 141:12 (2015), 1096–1103.
54. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention. 2013. Available at: < https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf> [accessed March 2017].
55. Manian, F.A., Meyer, P.L., Setzer, J., Senkel, D., Surgical site infections associated with methicillin-resistant staphylococcus aureus: do postoperative factors play a role?. Clin Infect Dis 36:7 (2003), 863–868.
56. Harbarth, S., Huttner, B., Gervaz, P., et al. Risk factors for methicillin-resistant staphylococcus aureus surgical site infection. Infect Control Hosp Epidemiol 29:9 (2008), 890–893.
57. Kalra, L., Camacho, F., Whitener, C.J., et al. Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control 41:12 (2013), 1253–1257.
58. Hirsch, E.B., Tam, V.H., Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res 10:4 (2010), 441–451.
59. Barlam, T.F., Cosgrove, S.E., Abbo, L.M., et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis 62:10 (2016), e51–e77.
60. Johnson, J.T., Schuller, D.E., Silver, F., et al. Antibiotic prophylaxis in high-risk head and neck surgery: One-day vs, five-day therapy. Otolaryngol Head Neck Surg 95:5 (1986), 554–557.
61. Mustafa, E., Tahsin, A., Cefotaxime prophylaxis in major non-contaminated head and neck surgery: one-day vs. seven-day therapy. J Laryngol Otol 107:1 (1993), 30–32.
62. Langerman, A., Thisted, R., Hohmann, S., Howell, M., Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg 154:6 (2016), 1054–1063.
63. Righi, M., Manfredi, R., Farneti, G., Pasquini, E., Cenacchi, V., Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery. Head Neck 18:5 (1996), 399–404.
64. Cohen, L.E., Finnerty, B.M., Golas, A.R., et al. Perioperative antibiotics in the setting of oropharyngeal reconstruction. Less is more. Ann Plast Surg. 76:6 (2016), 663–667.
65. Fee WE Jr, Glenn M, Handen C, Hopp ML. One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984;94(5 Pt 1):612–4.
66. Khariwala, S.S., Le, B., Pierce, B.H., Vogel, R.I., Chipman, J.G., Antibiotic use after free tissue reconstruction of head and neck defects: short course vs long course. Surg Infect (Larchmt) 17:1 (2016), 100–105.
67. Bhathena, H.M., Kavarana, N.M., Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime. Acta Chir Plast 40:2 (1998), 36–40.
68. Carroll, W.R., Rosenstiel, D., Fix, J.R., et al. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 129:7 (2003), 771–774.
69. Core elements for hospital antimicrobial stewardship programs. Centers for Disease Control and Prevention; 2017. Available at: < https://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html> [accessed March 2017].
70. Nicholas BD, Bhargave G, Hatipoglu A, Heffelfinger R, Rosen M, Pribitkin EA. Preoperative Prevalence of Methicillin-Resistant Staphylococcus Aureus (MRSA) colonization in patients undergoing intranasal surgery. Med Sci Monit 2010;16(8):CR365-8.
71. Kavanagh, K.T., Calderon, L.E., Saman, D.M., Abusalem, S.K., The use of surveillance and preventative measures for methicillin-resistant staphylococcus aureus infections in surgical patients. Antimicrob Resist Infect Control, 3, 2014, 18.
72. Supriya, M., Shakeel, M., Santangeli, L., Ah-See, K.W., Controlling MRSA in head and neck cancer patients: What works?. Otolaryngol Head Neck Surg 140:2 (2009), 224–227.
73. Lowe, C.F., Katz, K., McGeer, A.J., Muller, M.P., Toronto, E.S.B.L., Working Group. Efficacy of admission screening for extended-spectrum beta-lactamase producing enterobacteriaceae. PLoS ONE, 8(4), 2013, e62678.
74. Sidler JA, Frei R, Tschudin-Sutter S, et al. Is admission screening for Pseudomonas aeruginosa useful in haematologic patients? A prospective study with 1310 patients. Clin Microbiol Infect 2015;21(6):572.e1-3.
75. Farrell, J.J., Hicks, J.L., Wallace, S.E., Seftel, A.D., Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy. Res Rep Urol 9 (2017), 37–41.
76. Bradley, S.F., Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it?. Clin Infect Dis 44:2 (2007), 186–189.
77. Gerard, M., Meunier, F., Dor, P., Andry, G., Chantrain, G., Van der Auwera, P., et al. Antimicrobial prophylaxis for major head and neck surgery in cancer patients. Antimicrob Agents Chemother 32:10 (1988), 1557–1559.
78. Phan, M., Van der Auwera, P., Andry, G., Aoun, M., Chantrain, G., Deraemaecker, R., et al. Antimicrobial prophylaxis for major head and neck surgery in cancer Patients: Sulbactam-Ampicillin versus Clindamycin-Amikacin. Antimicrob Agents Chemother 36:9 (1992), 2014–2019.
79. Mücke T, Rohleder NH, Rau A, Ritschl LM, Kesting M, Wolff KD, et al. The value of perioperative antibiotics on the success of oral free flap reconstructions. Microsurgery 2015;35(7):507–11.